1. Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin 2009;59:8–24.
2. Basta MN, Wu LC, Kanchwala SK, et al. Reliable prediction of postmastectomy lymphedema: the Risk Assessment Tool Evaluating Lymphedema. Am J Surg 2017;213:1125–33.
3. DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013;14:500–15.
4. McDuff SGR, Mina AI, Brunelle CL, et al. Timing of lymphedema after treatment for breast cancer: when are patients most at risk? Int J Radiat Oncol Biol Phys 2019;103:62–70.
6. Dayan JH, Ly CL, Kataru RP, et al. Lymphedema: pathogenesis and novel therapies. Annu Rev Med 2018;69:263–76.
9. Gir P, Oni G, Brown SA, et al. Human adipose stem cells: current clinical applications. Plast Reconstr Surg 2012;129:1277–90.
10. Toyserkani NM, Christensen ML, Sheikh SP, et al. Stem cells show promising results for lymphoedema treatment: a literature review. J Plast Surg Hand Surg 2015;49:65–71.
14. Toyserkani NM, Jensen CH, Tabatabaeifar S, et al. Adipose-derived regenerative cells and fat grafting for treating breast cancer-related lymphedema: lymphoscintigraphic evaluation with 1 year of follow-up. J Plast Reconstr Aesthet Surg 2019;72:71–7.
15. Hwang JH, Kim IG, Lee JY, et al. Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Biomaterials 2011;32:4415–23.
16. Yan A, Avraham T, Zampell JC, et al. Adipose-derived stem cells promote lymphangiogenesis in response to VEGF-C stimulation or TGF-β1 inhibition. Future Oncol 2011;7:1457–73.
17. Strassburg S, Torio-Padron N, Finkenzeller G, et al. Adiposederived stem cells support lymphangiogenic parameters in vitro. J Cell Biochem 2016;117:2620–9.
18. Deng J, Dai T, Sun Y, et al. Overexpression of Prox1 induces the differentiation of human adipose-derived stem cells into lymphatic endothelial-like cells in vitro. Cell Reprogram 2017;19:54–63.
19. Sun Y, Lu B, Deng J, et al. IL-7 enhances the differentiation of adipose-derived stem cells toward lymphatic endothelial cells through AKT signaling. Cell Biol Int 2019;43:394–401.
20. Takeda K, Sowa Y, Nishino K, et al. Adipose-derived stem cells promote proliferation, migration, and tube formation of lymphatic endothelial cells in vitro by secreting lymphangiogenic factors. Ann Plast Surg 2015;74:728–36.
21. Saijo H, Suzuki K, Yoshimoto H, et al. Paracrine effects of adipose-derived stem cells promote lymphangiogenesis in irradiated lymphatic endothelial cells. Plast Reconstr Surg 2019;143:1189e–1200e.
23. Yoshida S, Hamuy R, Hamada Y, et al. Adipose-derived stem cell transplantation for therapeutic lymphangiogenesis in a mouse secondary lymphedema model. Regen Med 2015;10:549–62.
24. Hayashida K, Yoshida S, Yoshimoto H, et al. Adipose-derived stem cells and vascularized lymph node transfers successfully treat mouse hindlimb secondary lymphedema by early reconnection of the lymphatic system and lymphangiogenesis. Plast Reconstr Surg 2017;139:639–51.
25. Ackermann M, Wettstein R, Senaldi C, et al. Impact of platelet rich plasma and adipose stem cells on lymphangiogenesis in a murine tail lymphedema model. Microvasc Res 2015;102:78–85.
28. Forte AJ, Huayllani MT, Boczar D, et al. Bioimpedance spectroscopy for assessment of breast cancer-related lymphedema: a systematic review. Plast Surg Nurs 2020;40:86–90.
30. Kondo K, Kaneko T, Baba M, et al. VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol Pharm Bull 2007;30:633–7.
31. Wu SH, Shirado T, Mashiko T, et al. Therapeutic effects of human adipose-derived products on impaired wound healing in irradiated tissue. Plast Reconstr Surg 2018;142:383–91.
33. Zampell JC, Elhadad S, Avraham T, et al. Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury. Am J Physiol Cell Physiol 2012;302:C709–19.